Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$548K of HALO shares in the open market
Traded Jun 29, 2026 · Filed Jun 30, 2026
- ~$548K
- Reported value · 7,304 sh @ $75.00
- 14K
- Holds after · shares reported
- +40.3%
- stock since the trade · S&P 500 +4.6%, $77.18 → $108.31 on Oct 5
Why it stands out
A board member of Halozyme sold $548K of Halozyme shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 29, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 30, 2026
Director$500K–$1MPre-arranged plan referenced
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$547,800
Shares × reported transaction price
- Timing vs results
49 days after results of May 11, 2026, 38 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results